End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.69 CNY | -0.93% | +1.45% | -11.75% |
Apr. 29 | Liaoning Chengda Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 24 | Tech Sector Galvanizes Asian Stock Markets | MT |
Sales 2024 * | 2.05B 284M | Sales 2025 * | 2.51B 348M | Capitalization | 11.84B 1.64B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 5.77 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 4.71 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 1,732 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 40.37% |
1 day | -0.93% | ||
1 week | +1.45% | ||
Current month | +1.45% | ||
1 month | +3.09% | ||
3 months | -4.05% | ||
6 months | -14.82% | ||
Current year | -11.75% |
Managers | Title | Age | Since |
---|---|---|---|
Yu Mao
CEO | Chief Executive Officer | 44 | 07-06-30 |
Jian Wei Cui
DFI | Director of Finance/CFO | 46 | 22-01-25 |
Wei Qiang Sun
CTO | Chief Tech/Sci/R&D Officer | 64 | 18-08-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ning Li
CHM | Chairman | 55 | 05-12-31 |
Xiao Hui Liu
BRD | Director/Board Member | 55 | 20-02-29 |
Jun Wei Yang
BRD | Director/Board Member | 49 | 02-06-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 0 M€ | +3.63% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 28.69 | -0.93% | 1,329,807 |
24-05-09 | 28.96 | +0.52% | 1,451,758 |
24-05-08 | 28.81 | -0.24% | 1,218,186 |
24-05-07 | 28.88 | +0.03% | 1,196,349 |
End-of-day quote Shanghai S.E., May 09, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.75% | 1.64B | |
-2.61% | 89.08B | |
+3.55% | 40.9B | |
-14.40% | 32.25B | |
+55.89% | 25.14B | |
-15.96% | 15.39B | |
-15.50% | 11.91B | |
-41.29% | 11.89B | |
-11.75% | 11.64B | |
+7.87% | 9.03B |
- Stock Market
- Equities
- 688739 Stock